Login / Signup

Dasatinib, a selective tyrosine kinase inhibitor, prevents joint destruction in rheumatoid arthritis animal model.

Hong-Ki MinSe Hee KimJi-Yeon WonKyoung-Woon KimJi-Yeon LeeSang-Heon LeeHae-Rim Kim
Published in: International journal of rheumatic diseases (2023)
T cells and inhibiting osteoclastogenesis, indicating the therapeutic potential of dasatinib in the treatment of early RA.
Keyphrases
  • rheumatoid arthritis
  • disease activity
  • chronic myeloid leukemia
  • ankylosing spondylitis
  • signaling pathway
  • interstitial lung disease
  • lps induced
  • replacement therapy
  • idiopathic pulmonary fibrosis